Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Trump Secures Drug Pricing Deals With Nine Pharma Companies
OpenAI Rejects Apple Trade Secret Theft Claims
Jefferies Names AMEC Top China Semiconductor Equipment Pick
MediaTek Shares Jump 10% on Nvidia’s $3.5 Billion Investment
Star Entertainment Shares Fall After A$307 Million FY2026 Loss
Street Poller Media and The Boom of the Street Interview Ad Industry
Google Changes EU Spam Policy Amid Antitrust Scrutiny
GM Canada Workers Approve C$1.1 Billion Investment Deal
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
Shein Shares Slide 9% in Hong Kong IPO Debut
Faraday Future Delivers First Robots in Middle East, Plans September Launches
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 



